Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,440.00    -50.00 (-3.36%)
Bid:
1,434.00
Ask:
1,442.00
Spread: 8.00 (0.558%)
Market Cap: £493.01m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

AGM Statement

8 Nov 2017 07:00

RNS Number : 8493V
Craneware plc
08 November 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

AGM Statement

 

8 November 2017 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 2pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:

 

"We have experienced a positive start to trading in the first four months of the year, adding to the recent announcement of the $6m contract win extending the scope of our solutions within an existing customer. In June, we launched Trisus Claims Informatics, the first product on our cloud-based Trisus platform, to which we have seen a positive market response. In addition, we are seeing very encouraging results for the early adopters of our Trisus Cost Analytics Resource Efficiency product, which is currently under development within Craneware Healthcare Intelligence.

 

"The sales activity and the early product successes demonstrate how we are benefiting from our ongoing investments in our Value Cycle product suite, ensuring we have the solutions that provide insight into key areas of hospital operations, expanding our market opportunity and increasing our strategic value within our market.

 

"Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.

 

"This positive impact of the Value Cycle on current sales and underlying pipelines combined with the high levels of revenue visibility and significant cash reserves, means we are well positioned to continue to execute on our growth strategy."

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

Hilary Buchanan

George Sellar

Robyn Fisher

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBCBDBGGGBGRR
Date   Source Headline
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC
11th Jun 20252:40 pmGNWForm 8.3 - Craneware Plc
11th Jun 202512:02 pmGNWForm 8.3 - [CRANEWARE PLC - 10 06 2025] - (CGWL)
11th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) Craneware Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.